Building pharmacokinetic compartmental models using a superstructure approach

Abstract An optimization framework is presented to support the model builder in elucidating compartmental models that plausibly describe data obtained during experimentation. Here, one specifies a priori the maximum number of compartments and type of flows to contemplate during the optimization. The mathematical model follows a ‘superstructure’ approach, which inherently considers the different feasible flows between any pair of compartments. The model activates those flows/compartments that provide the optimal fit for a given set of experimental data. A regularized log-likelihood function is formulated as the performance metric. To deal with the resulting set of differential equations orthogonal collocation on finite elements is employed. A case study related to pharmacokinetics of an oncological agent demonstrates the advantages and limitations of the proposed approach. Numerical results show that the proposed approach can provide 33% smaller mean square prediction error in comparison with a compartmental model previously suggested in the literature.

[1]  T. Gooley,et al.  Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. , 2003, Blood.

[2]  M O Karlsson,et al.  A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients. , 1999, British journal of clinical pharmacology.

[3]  Venkat Venkatasubramanian,et al.  High fidelity mathematical model building with experimental data: A Bayesian approach , 2008, Comput. Chem. Eng..

[4]  Carl E. Rasmussen,et al.  Gaussian processes for machine learning , 2005, Adaptive computation and machine learning.

[5]  S. Gupta,et al.  Modeling the Cytotoxicity of Cisplatin , 2011 .

[6]  Gürkan Sin,et al.  First principles pharmacokinetic modeling: A quantitative study on Cyclosporin , 2013, Comput. Chem. Eng..

[7]  Luke E. K. Achenie,et al.  A mechanistic approach for modeling oral drug delivery , 2013, Comput. Chem. Eng..

[8]  Brian R. Phillips,et al.  Real-time Dose Adjustment of Cyclophosphamide in a Preparative Regimen for Hematopoietic Cell Transplant: A Bayesian Pharmacokinetic Approach , 2006, Clinical Cancer Research.

[9]  Seza Orcun,et al.  Comparison of an assumption‐free Bayesian approach with Optimal Sampling Schedule to a maximum a posteriori Approach for Personalizing Cyclophosphamide Dosing , 2014, Pharmacotherapy.

[10]  Richard E. Rosenthal,et al.  GAMS -- A User's Guide , 2004 .

[11]  J. E. Cuthrell,et al.  On the optimization of differential-algebraic process systems , 1987 .

[12]  Amber Jessup,et al.  Key cost drivers of pharmaceutical clinical trials in the United States , 2016, Clinical trials.

[13]  José Miguel Laínez,et al.  Flexible design‐planning of supply chain networks , 2009 .